Finding factors important for differentiation of antibody-secreting cells will help us engineer a B cell therapy for protein replacement or treat antibody-mediated disease.
We are building low- and high-throughput assays to study the function of variants in B cell-related to help improve the diagnosis and treatment of immunological disease.
Our Methods
We use quantitative proteomics, gene editing, next generation sequencing, flow cytometry, murine modeling, and computational approaches to accomplish our experimental goals.
Contact
Richard James
For questions or inquiries, 206. 884. 3290
Address
James Lab 1900 9th Avenue Seattle, WA 98101
By clicking “Accept All Cookies,” you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in marketing efforts. For more information, see Website Privacy.